Press release
Pancreatic Cancer Market Size Share Growth Opportunities and Forecast 2023-2030
Pancreatic Cancer Market-DataM Intelligence
Market Overview
In 2022, the global pancreatic cancer market surged to US$ 2.5 billion, and projections indicate a substantial growth trajectory, with an anticipated value of US$ 5.7 billion by 2030. The market is poised to exhibit a Compound Annual Growth Rate (CAGR) of 11.1% during the forecast period from 2023 to 2030.
Market Scope
Metrics:
CAGR: 11.1%
Size Available for Years: 2021-2030
Forecast Period: 2023-2030
Data Availability: Value (US$)
Segments Covered: Treatment Type, End User
Regions Covered: North America, Europe, Asia-Pacific, South America, Middle East & Africa
Fastest Growing Region: Asia-Pacific
Largest Region: North America
Report Insights Covered:
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter's Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights.
Download Free Sample: https://www.datamintelligence.com/download-sample/pancreatic-cancer-market
Market Dynamics
The rising prevalence of pancreatic cancer is propelling market growth globally. Pancreatic cancer, ranking as the fourth leading cause of cancer fatalities, exhibits higher incidence, prevalence, and mortality rates in nations with high Human Development Indices (HDI). Factors such as obesity, passive smoking, and chronic inflammation contribute to the increased incidence of pancreatic cancer.
FDA approvals for new products, such as MT-601, indicate a positive trend in the market. However, the market faces challenges due to side effects associated with therapeutics, impacting growth.
Segment Analysis
The global pancreatic cancer market is segmented based on treatment type, end-user, and region. Chemotherapy holds a dominant position, contributing approximately 37.6% to the market in 2022, with popular medications including Gemcitabine, 5-fluorouracil (5-FU), and Oxaliplatin.
To know more insights: https://www.datamintelligence.com/research-report/pancreatic-cancer-market
Geographical Penetration
North America commands a significant share, estimated at 39.3%, driven by rising pancreatic cancer cases and advancements in treatment and diagnosis.
Competitive Landscape
Key players in the global market include Myriad Genetics Inc., Pfizer Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Amgen Inc., Viatris Inc., Boston Scientific Corporation, Clovis Oncology, and GlaxoSmithKline.
By Treatment Type:
Targeted Therapies
Chemotherapy
Surgery
Other Treatments
By End-user:
Hospitals
Specialty Clinics
Home Care
Others
By Region:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Spain, Rest of Europe)
South America (Brazil, Argentina, Rest of South America)
Asia-Pacific (China, India, Japan, Australia, Rest of Asia-Pacific)
Middle East and Africa
Related Reports:
Locally Advanced Pancreatic Cancer Market: https://www.datamintelligence.com/research-report/locally-advanced-pancreatic-cancer-market
Exocrine Pancreatic Insufficiency Market: https://www.datamintelligence.com/research-report/exocrine-pancreatic-insufficiency-market
Artificial Pancreas Market: https://www.datamintelligence.com/research-report/artificial-pancreas-market
Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pancreatic Cancer Market Size Share Growth Opportunities and Forecast 2023-2030 here
News-ID: 3299453 • Views: …
More Releases from DataM Intelligence 4Market Research
IV Bags Market Set for Strong Growth as Hospital Admissions and Infusion Therapi …
Market Overview:
The IV Bags Market is expected to grow at a CAGR of 5% during the forecasting period 2024-2031.
The IV Bags Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it…
Feed Electrolytes Market is expected to reach US$ 28.3 billion by 2032 | Major p …
Market Size and Growth:
The Global Feed Electrolytes Market size reached US$ 3.64 billion in 2024 and is expected to reach US$ 28.3 billion by 2032, growing with a CAGR of 5.7% during the forecast period 2024-2032.
The Feed Electrolytes Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed…
Used Cooking Oil Market Set to Explode as Governments Push Circular Biofuel Solu …
Market Overview:
The Used Cooking Oil Market is expected to reach at a CAGR of 7.4% during the forecast period 2024-2031.
The Used Cooking Oil Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research…
Anionic Surfactant Market is expected to reach US$ 24.3 billion by 2032 | Major …
Market Size and Growth:
The Global Anionic Surfactant Market size reached US$ 14.7 billion in 2024 and is expected to reach US$ 24.3 billion by 2032, growing with a CAGR of 6.4% during the forecast period 2025-2032.
The Anionic Surfactant Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed…
More Releases for Pancreatic
Pancreatic Cancer Diagnostic Market Surges In Response To Escalating Prevalence …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Pancreatic Cancer Diagnostic Industry Market Size Be by 2025?
The sector dedicated to diagnosing pancreatic cancer has experienced significant upward momentum lately, projecting an expansion from a valuation of $4.24 billion in 2024 to $4.54 billion in 2025, reflecting a steady compound annual growth rate of…
Growing Pancreatic Cancer Cases : Pivotal Factor Influencing Pancreatic Cancer D …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pancreatic Cancer Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for pancreatic cancer drugs has seen consistent growth over the past few years. An escalation from $3.96 billion in 2024 to $4.1 billion in 2025 is projected, marking a compound annual…
Pancreatic Cancer Diagnostic Market Surges In Response To Escalating Prevalence …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Pancreatic Cancer Diagnostic Market Through 2025?
The market size for pancreatic cancer diagnostics has been witnessing robust growth in recent times. There will be a growth from $4.24 billion in 2024 to $4.55 billion in 2025, showcasing a Compound Annual Growth Rate…
Pancreatic Cancer Diagnostic Market Surges In Response To Escalating Prevalence …
The Pancreatic Cancer Diagnostic Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Pancreatic Cancer Diagnostic Market Size and Projected Growth Rate?
There has been a significant expansion in the pancreatic cancer diagnostic market recently. This market is projected to increase from a value…
Pancreatic Amylase Reagent Kits: Streamlining Enzyme Analysis for Efficient Panc …
Pancreatic Amylase Reagent Kits Market 2023 Forecast: Unveiling Opportunities and Growth
Pancreatic Amylase Reagent Kits Market research report helps to recognize the market challenges and opportunities. Global Pancreatic Amylase Reagent Kits Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of…
Pancreatic Cancer Therapy Market: Rise in Number of Patients Suffering with Panc …
Pancreatic cancer is one of the aggressive cancers that originate in the tissues of the pancreas and rapidly spreads to the nearby organs. Pancreatic cancer is the 12th most commonly occurring cancer in the world. According to the American Cancer Society, ~55,440 patients in the US are expected to be diagnosed with pancreatic cancer in 2018. Moreover, the ACS also reports that pancreatic cancer is the third leading cause of…
